Anemia Associated With Chronic Kidney Disease (CKD)
Hematology
2
Pipeline Programs
1
Companies
1
Clinical Trials
1
Approved Products
Pipeline by Development Stage
Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
0
0
0
1
1
Early DiscoveryClinical DevelopmentMarket
Drug Modality Breakdown
Small Molecule
1100%
On Market (1)
Approved therapies currently available
VAFSEOApproved
vadadustat
Akebia TherapeuticsHypoxia-inducible Factor Prolyl Hydroxylase Inhibitor [EPC]oral2024
Competitive Landscape
1 companies ranked by most advanced pipeline stage
Trial Timeline
Clinical trial activity over time
2021
2022
2023
2024
2025
2026
Akebia TherapeuticsVadadustat
Clinical Trials (1)
Study Evaluating the Efficacy and Safety of Dose Conversion From a Long-acting Erythropoiesis-stimulating Agent (Mircera®) to Three Times Weekly Oral Vadadustat for the Maintenance Treatment of Anemia in Hemodialysis Subjects
Start: Jun 2021Est. completion: Jan 2023
Phase 3Completed
Related Jobs in Hematology
MSL Hematología L - Sur
Johnson & Johnson
Sevilla, Spain
2d ago
Senior Manager – Strategy & Business Transformation
Johnson & Johnson
Mumbai, India
2d ago
Délégué Médical LLC/Myélome (H/F) - secteurToulouse
Johnson & Johnson
Issy-les-Moulineaux, France
2d ago
Sr. Director Marketing
Genetix Biotherapeutics
Somerville, Massachusetts, United States
4d ago
From $270K/yr
SALES REP SR - Hematologia (Ribeirão Preto/Sorocaba)
Novartis
Santo Amaro
5d ago
Hematology Field Medical Director, non-MD
Pfizer
Remote
5d ago
$177K - $294K/yr
Phase Legend
Preclinical— Lab & animal studies
Phase 1— Safety & dosing
Phase 2— Efficacy testing
Phase 3— Large-scale trials
On Market— Approved & available
Key Insights
1 late-stage (Phase 3) programs — potential near-term approvals
1 companies competing in this space